Lipid-mediated resistance of Gram-negative bacteria against various pore-forming antimicrobial peptides

Abstract

Lipopolysaccharides (LPSs) play a dual role as target and as effector molecules. The knowledge of the LPS-induced activation of human immune cells is increasing; however, surprisingly, much less effort seems to be directed towards the understanding of the mechanisms leading to the killing of the bacterial organisms, which eventually results in the release of LPS from the bacterial surface into the blood circulation. We demonstrate mechanisms of interaction of peptides of the innate immune system (e.g. defensins and cathelicidins) as well as of externally administered antibiotics (e.g. Polymyxin B) with Gram-negative bacteria. The main focus is directed on data derived from electrical measurements on a reconstitution system of the outer membrane as an asymmetric bilayer composed on one side of LPS and on the other of phospholipids. All these antimicrobial peptides (AMPs) are membrane-active and induce the permeabilization of the reconstituted membranes by the formation of lesions. We found that differences in the activity of the AMPs against various sensitive and resistant Gram-negative bacteria can be explained solely by variations in the chemical structure of LPS, e.g. in the composition of the sugar head group. A reduction of the net negative charge of LPS is responsible for a reduced interaction with the polycationic AMPs and thus for resistance. A most important side effect of positively charged AMPs is the neutralization of the negatively charged LPS released from the bacterial surface as a consequence of AMP-induced killing.

Keywords

Gram-negative bacteria antimicrobial peptides resistance defensins cathelicidins Polymyxin B

References

Elsbach P. The bactericidal/permeability-increasing protein (BPI) in antibacterial host defense. J Leukoc Biol 1998; 64: 14—18.

Diamond G. , Bevins CL β-Defensins: endogenous antibiotics of the innate host defense response . Clin Immunol Immunopathol 1998; 88: 221—225.

Bals R. , Wang X. , Zasloff M. , Wilson JM The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc Natl Acad Sci USA 1998; 95: 9541—9546.

Lugtenberg B. , Van Alphen L. Molecular architecture and functioning of the outer membrane of Escherichia coli and other Gram-negative bacteria. Biochim Biophys Acta 1983; 737: 51—115.

Benz R. , Bauer K. Permeation of hydrophilic molecules through the outer membrane of Gram-negative bacteria. Review on bacterial porins. Eur J Biochem 1988; 176: 1—19.

Hancock Rew. Alterations in outer membrane permeability. Annu Rev Microbiol 1984; 38: 237—264.

Wiese A. , Brandenburg K. , Carroll SF , Rietschel ETh , Seydel U. Mechanisms of action of the bactericidal/permeability-increasing protein BPI on reconstituted outer membranes of Gram-negative bacteria. Biochemistry 1997; 36: 10311—10319.

Gutsmann T. , Larrick JW , Seydel U. , Wiese A. Molecular mechanisms of interaction of rabbit CAP18 with outer membranes of Gram-negative bacteria. Biochemistry 1999; 38: 13643—13653.

Gutsmann T. , Hagge SO , Larrick JW , Seydel U. , Wiese A. Interaction of CAP18-derived peptides with membranes made from endotoxins or phospholipids. Biophys J 2001; 80: 2935—2945.

10.

Wiese A. , Münstermann M. , Gutsmann T. et al. Molecular mechanisms of Polymyxin B-membrane interactions: direct correlation between surface charge density and self-promoted uptake. J Membr Biol 1998; 162: 127—138.

11.

Montal M. , Mueller P. Formation of bimolecular membranes from lipid monolayers and a study of their electrical properties. Proc Natl Acad Sci USA 1972; 69: 3561—3566.

12.

Osborn MJ , Gander JE , Parisi E. , Carson J. Mechanism and assembly of the outer membrane of Salmonella typhimurium. J Biol Chem 1972; 247: 3962—3972.

13.

Wiese A. , Seydel U. Electrophysiological measurements on reconstituted outer membranes. Methods Mol Biol 1999; 145: 355—370.

14.

Zanetti M. , Gennaro R. , Romeo D. Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett 1995; 374: 1—5.

15.

Hirata M. , Zhong J. , Wright SC , Larrick JW Structure and functions of endotoxin-binding peptides derived from CAP18. Prog Clin Biol Res 1995; 392: 317—326.

16.

Travis SM , Anderson NN , Forsyth WR et al. Bactericidal activity of mammalian cathelicidin-derived peptides . Infect Immun 2000; 68: 2748—2755.

17.

Sen K. , Hellman J. , Nikaido H. Porin channels in intact cells of Escherichia coli are not affected by Donnan potentials across the outer membrane. J Biol Chem 1988; 263: 1182—1187.

18.

Lehrer RI , Ganz T. Defensins of vertebrate animals. Curr Opin Immunol 2002; 14: 96—102.

19.

Harder J. , Bartels J. , Christophers E. , Schroder JM Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. J Biol Chem 2001; 276: 5707—5713.

20.

Weiss J. , Olsson I. Cellular and subcellular localization of the bactericidal/permeability-increasing protein of neutrophils. Blood 1987; 69: 652—659.

21.

Weiss J. , Elsbach P. , Olsson I. , Odeberg H. Purification and characterization of a potent bactericidal and membrane active protein from the granules of human polymorphonuclear leukocytes. J Biol Chem 1978; 253: 2664—2672.

22.

Elsbach P. , Weiss J. , Franson RC et al. Separation and purification of a potent bactericidal/permeability-increasing protein and a closely associated phospholipase A2 from rabbit polymorphonuclear leukocytes. J Biol Chem 1979; 254: 11000—11009.

23.

Gazzano-Santoro H. , Parent JB , Conlon PJ et al. Characterization of the structural elements in lipid A required for binding of a recombinant fragment of bactericidal/permeability-increasing protein rBPI23. Infect Immun 1995; 63: 2201—2205.

24.

Ooi CE , Weiss J. , Doerfler ME , Elsbach P. Endotoxin-neutralizing properties of the 25 kD N-terminal fragment of the 55—60 kD bactericidal/permeability-increasing protein of human neutrophils . J Exp Med 1991; 174: 649—655.

25.

Capodici C. , Chen S. , Sidorczyk Z. , Elsbach P. , Weiss J. Effect of lipopolysaccharide (LPS) chain length on interactions of bactericidal/permeability-increasing protein and its bioactive 23-kilodalton NH2-terminal-fragment with isolated LPS and intact Proteus mirabilis and Escherichia coli. Infect Immun 1994; 62: 259—265.

26.

Gazzano-Santoro H. , Parent JB , Grinna L. et al. High-affinity binding of the bactericidal/permeability-increasing protein and a recombinant amino-terminal fragment to the lipid A region of lipopolysaccharide. Infect Immun 1992; 60: 4754—4761.

27.

Huang K. , Fishwild DM , Wu H-M. , Dedrick RL Lipopolysaccharide-induced E-selectin expression requires continuous presence of LPS and is inhibited by bactericidal/permeability-increasing protein. Inflammation 1995; 19: 389—404.

28.

Wiese A. , Brandenburg K. , Lindner B. et al. Mechanisms of action of the bactericidal/permeability-increasing protein BPI on endotoxin and phospholipid monolayers and aggregates. Biochemistry 1997; 36: 10301—10310.